Analyst Price Target is $2.95
▲ +146.10% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for IceCure Medical in the last 3 months. The average price target is $2.95, with a high forecast of $3.00 and a low forecast of $2.90. The average price target represents a 146.10% upside from the last price of $1.20.
Current Consensus is
Buy
The current consensus among 2 polled investment analysts is to buy stock in IceCure Medical. This Buy consensus rating has held steady for over two years.
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Read More